Get startedLog in
    Picture of ExpreS2ion Biotech Holding AB logo

    EXPRS2 — ExpreS2ion Biotech Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Expres2ion Biotech Announces Positive Results From Covid-19 Study With Abncov2

    Picture of ExpreS2ion Biotech Holding AB logoExpreS2ion Biotech Holding AB
    12/11/2021 07:43
    Nov 12 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * FURTHER EFFICACY DATA FROM THE COVID-19 CLINICAL PHASE
I/II
STUDY WITH ABNCOV2 CONFIRMS STRONG POSITIVE RESULTS
    * HEADLINE RESULTS MET ITS SAFETY AND EFFICACY ENDPOINTS
ALSO FOR
THESE DOSE RANGES, AND THUS FOR STUDY IN ITS ENTIRETY.

Source text for Eikon:  ID:nWkr3q9RWh 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on ExpreS2ion Biotech Holding AB

    See all news